FDA Approves Unknown Drug — RISING
On August 8, Rising received final approval for its ANDA090943, positioning the company to compete in the market for the undisclosed substance. This approval allows the generic drug to enter the commercial space immediately, subject to any competing brand exclusivity.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed